CancerLinker: Explorations of Cancer Study Network
This tool addresses the need for interactive visualization to aid biologists and cancer researchers in understanding protein interactions across pathways, though it is incremental as it builds on existing data and methods.
The authors tackled the problem of exploring complex relationships among proteins across multiple cancer studies by developing CancerLinker, a visual analytic tool that merges 26 cancer studies into a single network to help biologists detect common proteins and interaction patterns.
Interactive visualization tools are highly desirable to biologist and cancer researchers to explore the complex structures, detect patterns and find out the relationships among bio-molecules responsible for a cancer type. A pathway contains various bio-molecules in different layers of the cell which is responsible for specific cancer type. Researchers are highly interested in understanding the relationships among the proteins of different pathways and furthermore want to know how those proteins are interacting in different pathways for various cancer types. Biologists find it useful to merge the data of different cancer studies in a single network and see the relationships among the different proteins which can help them detect the common proteins in cancer studies and hence reveal the pattern of interactions of those proteins. We introduce the CancerLinker, a visual analytic tool that helps researchers explore cancer study interaction network. Twenty-six cancer studies are merged to explore pathway data and bio-molecules relationships that can provide the answers to some significant questions which are helpful in cancer research. The CancerLinker also helps biologists explore the critical mutated proteins in multiple cancer studies. A bubble graph is constructed to visualize common protein based on its frequency and biological assemblies. Parallel coordinates highlight patterns of patient profiles (obtained from cBioportal by WebAPI services) on different attributes for a specified cancer study